Management of systemic and pulmonary hypertension

Texas Heart Institute Journal

Volumn 32, Issue 4, 2005, Pages 467-471

  Levy, Jerrold H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension, perioperative; Nicardipine; Nitrovasodilators; Vasodilator drugs; Vasospasm, coronary

Indexed keywords

ADENOSINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLEVIDIPINE; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; ENALAPRILAT; GANGLION BLOCKING AGENT; GLYCERYL TRINITRATE; HYDRALAZINE; HYPOCHOLESTEROLEMIC AGENT; ISRADIPINE; MILRINONE; NESIRITIDE; NICARDIPINE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E1; UNINDEXED DRUG; VASOACTIVE AGENT; VASODILATOR AGENT;

CALCIUM CURRENT; CONFERENCE PAPER; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DRUG TOLERANCE; HEART MUSCLE; HEART SURGERY; HUMAN; HYPERTENSION; INOTROPISM; INTERNAL MAMMARY ARTERY; INTRACRANIAL PRESSURE; METABOLIC ACIDOSIS; PULMONARY HYPERTENSION; TACHYCARDIA; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; VASOSPASM;

CARDIAC SURGICAL PROCEDURES; HEART DISEASES; HUMANS; HYPERTENSION; HYPERTENSION, PULMONARY; PERIOPERATIVE CARE; TREATMENT OUTCOME; VASODILATION; VASODILATOR AGENTS;

EID: 33244466298     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Vuylsteke A, Feneck RO, Jolin-Mellgard A, Latimer RD, Levy JH, Lynch C 3rd, et al. Perioperative blood pressure control: a prospective survey of patient management in cardiac surgery. J Cardiothorac Vasc Anesth 2000;14:269-73.
2. Levy JH. The ideal agent for perioperative hypertension and potential cytoprotective effects. Acta Anaesthesiol Scand Suppl 1993;99:20-5.
3. Huraux C, Makita T, Kurz S, Yamaguchi K, Szlam F, Tarpey MM, et al. Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. Circulation 1999;99:53-9.
4. Harrison DG, Bates JN. The nitrovasodilators. New ideas about old drugs. Circulation 1993;87:1461-7.
5. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med 1998;338:520-31.
6. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995;95:187-94.
7. Munzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci U S A 1995;92:5244-8.
8. Munzel T, Heitzer T, Kurz S, Harrison DG, Luhman C, Pape L, et al. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease. J Am Coll Cardiol 1996;27:297-303.
9. Nishiyama T, Yokoyama T, Matsukawa T, Hanaoka K. Continuous nicardipine infusion to control blood pressure after evacuation of acute cerebral hemorrhage. Can J Anaesth 2000;47:1196-201.
10. Lambert CR, Hill JA, Feldman RL, Pepine CJ. Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris. Am J Cardiol 1987;60:471-6.
11. Lambert CR, Hill JA, Nichols WW, Feldman RL, Pepine CJ. Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol 1985;55:652-6.
12. Visser CA, Jaarsma W, Kan G, Lie KI. Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease. Postgrad Med J 1984;60 Suppl 4:17-20.
13. Silke B, Verma SP, Frais MA, Hafizullah M, Taylor SH. Effects of nicardipine on cardiac volume at rest and during exercise-induced angina. Br J Clin Pharmacol 1985;20 Suppl 1:169S-176S.
14. Singh BN, Josephson MA. Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine. Am Heart J 1990;119(2 Pt 2):427-34.
15. Cardene® IV [package insert]. Edison, NJ: ESP Pharma, Inc.; 2005.
16. Cheung AT, Guvakov DV, Weiss SJ, Savino JS, Salgo IS, Meng QC. Nicardipine intravenous bolus dosing for acutely decreasing arterial blood pressure during general anesthesia for cardiac operations: pharmacokinetics, pharmacodynamics, and associated effects on left ventricular function. Anesth Analg 1999;89:1116-23.
17. Leslie J, Brister N, Levy JH, Yared JP, Marty A, Martin H, et al. Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside. Circulation 1994;90(5 Pt 2):II256-61.
18. Bailey JM, Lu W, Levy JH, Ramsay JG, Shore-Lesserson L, Prielipp RC, et al. Clevidipine in adult cardiac surgical patients: a dose-finding study. Anesthesiology 2002;96:1086-94.
19. Huraux C, Makita T, Montes F, Szlam F, Levy JH. A comparative evaluation of the effects of multiple vasodilators on human internal mammary artery. Anesthesiology 1998:88:1654-9.
20. He GW, Yang CQ. Comparative study on calcium channel antagonists in the human radial artery: clinical implications. J Thorac Cardiovasc Surg 2000;119:94-100.